Ge Healthcare Technologies Inc.
GE HealthCare Technologies Realigns Reportable Segments
Summary
GE HealthCare Technologies Inc. announced a realignment of its reportable segments effective July 1, 2024, as disclosed under Item 7.01. The Image Guided Therapies (IGT) segment was moved from the Imaging segment to the Ultrasound segment, which was renamed to Advanced Visualization Solutions (AVS). This realignment better matches clinical usage and aims to enhance business and customer impact. The Company continues to operate four reportable segments: Imaging, AVS, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Recast unaudited historical financial information reflecting the new segment structure is provided in Exhibit 99, which is not included in this filing but referenced for comparability purposes.
Get alerts for GEHC
Be first to know when Ge Healthcare Technologies Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc. is a prominent player in the healthcare industry, focused on providing transformative medical technology and diagnostic solutions. Specializing in imaging, monitoring, and diagnostic equipment, the company plays a crucial role in enhancing clinical outcomes, improving patient care, and driving medical technology innovations. Ge Healthcare Technologies Inc. is recognized for its advancements in medical imaging systems, including MRI, CT, and ultrasound technologies, which aid in early disease detection and treatment planning. In addition to its hardware innovations, the company is actively involved in digital healthcare solutions, employing data analytics and AI to support precise diagnoses and personalized medicine. The impact of Ge Healthcare Technologies extends across various healthcare sectors, including hospitals, clinics, and research institutions, underscoring its importance in advancing clinical capabilities and operational efficiencies within the healthcare system. Ge Healthcare Technologies Inc. maintains a strategic presence in global markets, bolstering healthcare infrastructure and supporting public health initiatives. By continuously striving to innovate and improve healthcare delivery, it remains a significant entity within the broader medical technology and life sciences industry, contributing to the future of healthcare.
Official SEC Documents
Advertisement